I watched enterprises buy AI that solved the wrong problem. So I left Dell and built a startup to fix it

The article discusses inefficiencies in healthcare decision-making processes, such as delays in drug coverage approvals leading to high costs and patient harm. It critiques enterprise AI deployments for failing to address systemic issues, citing MIT and Gartner research showing most AI projects lack measurable returns. The author left Dell to build a startup aiming to improve AI's role in healthcare by focusing on managing AI systems rather than just expanding their use.